497155-61-0
Catalog No.:AA00DHNS

497155-61-0 | GLUCOCEREBROSIDES

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
≥98%
in stock  
$159.00   $111.00
- +
10mg
≥98%
in stock  
$253.00   $177.00
- +
50mg
≥98%
in stock  
$1,172.00   $820.00
- +
100mg
≥98%
in stock  
$2,168.00   $1,517.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00DHNS
Chemical Name:
GLUCOCEREBROSIDES
CAS Number:
497155-61-0
Molecular Formula:
C40H75NO9
Molecular Weight:
714.0248
SMILES:
CCCCCCCCCCCCCCC(C(=O)N[C@H]([C@@H](/C=C/CC/C=C/CCCCCCCCC)O)CO[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O)O
Properties
Computed Properties
 
Complexity:
857  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
7  
Defined Bond Stereocenter Count:
2  
Heavy Atom Count:
50  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
7  
Rotatable Bond Count:
32  
Undefined Atom Stereocenter Count:
1  
XLogP3:
9.6  

Literature

Title: Glucosylceramide and lysophosphatidylcholines as potential blood biomarkers for drug-induced hepatic phospholipidosis.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20141001

Title: Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells.

Journal: Nutrition and cancer 20110101

Title: Changes in the atherogenic profile of patients with type 1 Gaucher disease after miglustat therapy.

Journal: Atherosclerosis 20100401

Title: Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis.

Journal: The Journal of biological chemistry 20040227

Title: Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells.

Journal: Journal of neurochemistry 19990301

Title: Rationales for cancer chemotherapy with PDMP, a specific inhibitor of glucosylceramide synthase.

Journal: Molecular and chemical neuropathology 19940101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:497155-61-0 Molecular Formula|497155-61-0 MDL|497155-61-0 SMILES|497155-61-0 GLUCOCEREBROSIDES
Catalog No.: AA00DHNS
497155-61-0
497155-61-0 | GLUCOCEREBROSIDES
Pack Size: 5mg
Purity: ≥98%
in stock
$159.00 $111.00
Pack Size: 10mg
Purity: ≥98%
in stock
$253.00 $177.00
Pack Size: 50mg
Purity: ≥98%
in stock
$1,172.00 $820.00
Pack Size: 100mg
Purity: ≥98%
in stock
$2,168.00 $1,517.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00DHNS
Chemical Name: GLUCOCEREBROSIDES
CAS Number: 497155-61-0
Molecular Formula: C40H75NO9
Molecular Weight: 714.0248
SMILES: CCCCCCCCCCCCCCC(C(=O)N[C@H]([C@@H](/C=C/CC/C=C/CCCCCCCCC)O)CO[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O)O
Properties
Complexity: 857  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 7  
Defined Bond Stereocenter Count: 2  
Heavy Atom Count: 50  
Hydrogen Bond Acceptor Count: 9  
Hydrogen Bond Donor Count: 7  
Rotatable Bond Count: 32  
Undefined Atom Stereocenter Count: 1  
XLogP3: 9.6  
Literature fold

Title: Glucosylceramide and lysophosphatidylcholines as potential blood biomarkers for drug-induced hepatic phospholipidosis.

Journal: Toxicological sciences : an official journal of the Society of Toxicology20141001

Title: Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells.

Journal: Nutrition and cancer20110101

Title: Changes in the atherogenic profile of patients with type 1 Gaucher disease after miglustat therapy.

Journal: Atherosclerosis20100401

Title: Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis.

Journal: The Journal of biological chemistry20040227

Title: Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells.

Journal: Journal of neurochemistry19990301

Title: Rationales for cancer chemotherapy with PDMP, a specific inhibitor of glucosylceramide synthase.

Journal: Molecular and chemical neuropathology19940101

Building Blocks More >
49672-69-7
49672-69-7
1,4-Dioxaspiro[4.5]decan-7-amine
AA00DHUM | MFCD19373870
52804-26-9
52804-26-9
[4-(1-Adamantyl)phenoxy]acetic acid
AA00DIBU | MFCD00168197
52034-14-7
52034-14-7
5-HEXENYLTRIETHOXYSILANE
AA00DII3 | MFCD08702782
477851-07-3
477851-07-3
1-Oxo-2-(pyridin-3-ylmethyl)-1,2-dihydroisoquinoline-4-carboxylic acid
AA00DIUT | MFCD00140332
54659-69-7
54659-69-7
2-(4-(tert-Butyl)phenoxy)nicotinic acid
AA00DJ1C | MFCD00067839
474688-74-9
474688-74-9
9-([1,1':3',1''-Terphenyl]-5'-yl)-10-bromoanthracene
AA00DJH5 | MFCD26406220
483366-98-9
483366-98-9
4-Methylpiperidin-4-amine dihydrochloride
AA00DJPV | MFCD15474937
52239-63-1
52239-63-1
THIETHYLPERAZINE MALATE
AA00DK0A | MFCD01706868
478834-25-2
478834-25-2
4-Chloro-1h-indazol-5-ol
AA00DKBW | MFCD16659073
544451-83-4
544451-83-4
Methyl 4-ethanesulfonamidobenzoate
AA00DKH4 | MFCD03379139
Submit
© 2017 AA BLOCKS, INC. All rights reserved.